Pharmaceutical company intelligence

Neutro Pharma (Pvt.) Ltd.,

Private pharmaceutical and nutraceutical manufacturer · Lahore · Pakistan

Lahore-based pharmaceutical and wellness company manufacturing pharmaceuticals, nutraceuticals and specialty healthcare products.

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.

Official website ↗ Official contact ↗

Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details

Latest regulatory-source observation23 Sep 2026Newest linked source record observed by MedInfoBase

Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio

Latest effective price date4 Aug 2026Newest effective date among published current price records

Corporate profile evidence5 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Location intelligence

Company location

Google Maps

Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗

Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view

Rx211public portfolio records represented

REG189unique registrations represented

IDX10indexed MedInfoBase presentations

SRC0additional source-observed presentations

R+0registry-only registrations

VER0registry-verified exact registrations

PKR204current validated price records

G97generic molecules in indexed catalogue

DF12dosage-form groups

TA15therapeutic areas

How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage97%

public portfolio presentations with a validated current price

Official-source coverage100%

products linked back to a source record

Unit-price parse coverage95%

priced packs safely normalized per unit

Comparable-market coverage83%

products with at least one like-for-like comparator

Therapeutic classification100%

products assigned to a broad therapeutic area

Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives93 products · 44%

CNS & mental health31 products · 15%

Fluids & supportive care24 products · 11%

Oncology & immunology9 products · 4%

Cross-therapeutic & anti-inflammatory8 products · 4%

Gastrointestinal & hepatology8 products · 4%

Vitamins, minerals & nutrition7 products · 3%

Dermatology6 products · 3%

Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Fluids, electrolytes & diluents24 products · 11%

Antivirals18 products · 9%

Third-generation cephalosporins16 products · 8%

Antipsychotics14 products · 7%

Fluoroquinolone antibacterials13 products · 6%

Antimalarials11 products · 5%

Macrolide antibacterials10 products · 5%

Antiepileptics10 products · 5%

Formulation footprint

Dosage forms

Tablet74 products

Injection55 products

Capsule24 products

Infusion23 products

Suspension18 products

Cream6 products

Sachet3 products

Solution2 products

Syrup2 products

Drops1 products

Inhalation1 products

Other1 products

How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales

#1 NeucludEntecavir 6presentations 0.05 mg/mL, 0.5 mg, 1 mg · Solution, Tablet #2 NlyteDextrose + Sodium chloride 6presentations 3.3% + 0.3%, NaCl 0.3g + Dextrose 3.3g/100 mL, NaCl 0.45g + Dextrose 10g/100 mL, NaCl 0.45g + Dextrose 5.0g/100 mL · Infusion #3 VexaCeftriaxone 6presentations 1 g, 1.0 g, 250 mg, 500 mg · Injection #4 AffifCiprofloxacin 5presentations 125 mg/5 mL, 200 mg, 250 mg, 250 mg/5 mL · Suspension, Infusion, Tablet #5 NeurivoxRivaroxaban 5presentations 10 mg, 15 mg, 20 mg · Tablet #6 NeutrolineWater for Injection 5presentations 10 mL, 20 mL presentation, 5 mL · Injection

Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis

Below market median5129% of comparable products

Near market median77within ±5% of median

Above market median4626% of comparable products

Lowest-price equivalents21ties included

Company median price position +0.2% relative to the median unit price of like-for-like equivalent products.

Most competitively positioned examplesProducts with at least 3 market comparators

Neuvanco concentrate for 500 mgVancomycin · Injection · 10's PKR 113.68/vial/unit-91.0% vs market median Neupencilin 250 mgPenicillamine · Tablet · 10's PKR 29.92/tablet-70.0% vs market median Dianext MR 60 mgGliclazide · Modified-release tablet · 20's PKR 11.47/tablet-65.3% vs market median Dermacort-B w/w 0.1 %Betamethasone · Cream · 15gm PKR 2.00/g-60.3% vs market median Silvia 1 %Sulphadiazine · Cream · 500gm PKR 1.60/g-59.9% vs market median

How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Pharmasol (Pvt) Ltd.257 products · 102 generics 51shared generics M/s. Genix Pharma (Pvt) Ltd.297 products · 97 generics 50shared generics Bio-Labs(Pvt) Ltd236 products · 82 generics 47shared generics Mediate Pharmaceutical Pvt Ltd236 products · 90 generics 46shared generics Nabiqasim Industries (Pvt) Ltd.,365 products · 118 generics 45shared generics Valor Pharmaceuticals219 products · 97 generics 44shared generics

Regulatory & price activity

Observed database signals

Indexed registration numbers188Distinct registrations among indexed, published, presentation-validated products only

Verified price observations210

Products with a verified price210

Products with multiple price observations0

Source records with multiple versions209

Latest portfolio source check22 Sep 2026

Latest effective price date4 Aug 2026

Latest source observation23 Sep 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

189 unique registration(s) · 10 indexed presentation(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Intelligence filter: Drug classAntiepileptics Clear intelligence filters

Brand	Generic	Strength	Form	Pack	Registration	Source-listed price	Unit price	Price position
Carbalan	Carbamazepine	200 mg	Tablet	30's	105636	PKR 324.50	PKR 10.82/tablet	Near median
Depilap	Sodium valproate	250 mg/5 mL	Syrup	60ml	059835	PKR 99.73	PKR 1.66/mL	9% below median
Depilap	Divalproex sodium	500 mg	Tablet	20's	062769	PKR 269.84	PKR 13.49/tablet	16% above median
Depilap	Divalproex sodium	500 mg	Tablet	10x10's	062769	PKR 1,323.73	PKR 13.24/tablet	14% above median
Neutolev	Levetiracetam	500 mg/5 mL	IV injection/infusion	1'sLDPE	109657	PKR 470.63	—	No comparator
Neutolev	Levetiracetam	500 mg/5 mL	Injection	1'sLDPE	109657	PKR 470.63	—	No comparator
Nubarbi	Phenobarbital	200 mg	Injection	200x2ml	065757	PKR 417.49	PKR 1.04/mL	No comparator
Nubarbi	Phenobarbital	30 mg	Tablet	100's	065781	PKR 84.77	PKR 0.85/tablet	5% below median
Racpine	Carbamazepine	100 mg/5 mL	Suspension	120ml	111960	PKR 211.94	PKR 1.77/mL	Near median
Serliv	Levetiracetam	500 mg	Tablet	10's	069300	PKR 1,021.87	PKR 102.19/tablet	8% above median

MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record

MedInfoBase. (2026). Neutro Pharma (Pvt.) Ltd — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved September 23, 2026, from https://medinfobase.com/company/neutro-pharma-pvt-ltd/

Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.

Neutro Pharma (Pvt.) Ltd.,

What is sourced, and how recent is it?

Company profile

Company location

Portfolio at a glance

How complete is this profile?

Downloadable company intelligence charts

Therapeutic Portfolio Mix

Dosage Form Portfolio

Equivalent Price Position

Closest Portfolio Competitors

Therapeutic areas

Drug classes

Dosage forms

Deepest brand families

Unit-price positioning vs equivalent products

Portfolio overlap

Observed database signals

Medicine portfolio

Cite this record